ABSI

NASD Absci Corporation
Oct 21, 2026 · 7:10 PM ET LAST TRADE Market Closed

$10.00 ↓ -0.04 (-0.40%) Trading Down from the previous close of $10.04, $0.21 below the day’s high of $10.21

YTD change
+186.53%
vs 20-day SMA
+2.87%
vs 200-day SMA
+60.95%

Price ranges

Previous day
$8.22 $9.10
open $8.50 close $9.07
+$0.57 (+6.71%)
Today
$9.11 $10.21
open $9.24 now $10.00
+$0.76 (+8.23%)
Past week
$8.12 $9.12
from $9.10 now $10.00
+$0.90 (+9.89%)
Past month
$8.12 $11.89
from $10.71 now $10.00
-$0.71 (-6.63%)
This year
$2.24 $12.06
from $3.49 now $10.00
+$6.51 (+186.53%)

Price & Performance

+5.17 (+132.56%) / 6M

$3.04$6.11$9.19$12.26Apr 21Jul 22Oct 20

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 68.3% away from all-time highs of $31.53
  • ABSI is up 187% since the beginning of the year
  • ABSI is up 117% over the past 12 months
  • ABSI is down 7% over the past 1 month
  • 24% of all ABSI investors are betting against ABSI

ABSI reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +96.7%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.21
Earnings momentum -10.6% Quarterly EPS growth
Quarterly change -10.6%

Valuation

P/E ratio N/A
Enterprise value $1.2B
Beta 3.28

Balance sheet & scale

IncomeN/A
Revenue$1.6M
Cash$201.1M
Debt$3.8K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $1.7B

Absci Corp. engages in drug discovery with generative design to create biologics for patients. Its platform combines AI models with a synthetic biology data engine, enabling the design of therapeutics that address challenging therapeutic targets. The firm has its own pipeline of AI designed therapeutics including ABS-201 and ABS-202. Absci Corp was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $438.94 +3.29%
MRNA Moderna, Inc. $242.08 +6.69%
RVMD Revolution Medicines, Inc. $196.55 +7.91%
ROIV Roivant Sciences Ltd. $34.92 +0.63%
BNTX BioNTech SE Sponsored ADR $91.17 +2.20%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.